PSC Biotech to sell Clever Culture Systems’ AI microbiology platform in three markets

PSC Biotech has become the sole sales agent for Clever Culture Systems’ APAS® Independence in the U.S., Canada and Singapore pharma markets. The deal pairs AI-enabled culture plate reading with PSC Biotech’s validation and compliance services, and adds a live demonstration site in Pennsylvania.

Why it matters: - Pharmaceutical manufacturers are under pressure to speed up microbiology testing without losing data quality or compliance. - APAS® Independence is positioned to reduce manual plate reading in environmental monitoring workflows. - PSC Biotech’s validation support could make adoption easier inside regulated GMP environments.

What happened: - PSC Biotech was named the sole sales agent for Clever Culture Systems’ APAS® Independence across the pharmaceutical manufacturing market in the United States, Canada and Singapore. - The arrangement expands PSC Biotech’s role in bringing AI-enabled microbiology automation to life sciences customers. - PSC Biotech will install an APAS® Independence instrument at BioTechnique, its sterile fill-finish contract manufacturing facility in York, Pennsylvania. - The onsite system will be qualified and validated for GMP use. - The BioTechnique site will serve as a U.S. Center of Excellence for demonstrations and evaluations.

The details: - APAS® Independence uses artificial intelligence and machine learning to automate imaging, analysis and interpretation of microbiology culture plates. - The platform remains the only U.S. FDA-cleared artificial intelligence technology for automated culture plate reading. - In pharmaceutical manufacturing, APAS® Independence reads environmental monitoring plates. - PSC Biotech said the platform will help microbiology laboratories reduce manual plate reading and improve consistency. - PSC Biotech brings 30 years of experience in pharmaceutical consulting, validation and compliance. - PSC Biotech plans to introduce APAS® Independence to its network of pharmaceutical manufacturers. - The company said customers will gain access to both the technology and local expertise for qualification and validation in regulated GMP settings. - PSC Biotech also represents De Lama sterilization and decontamination systems, Climet particle counters and microbial air samplers, and Blue Ocean Robotics’ UVD Robot Pharma autonomous UV-C disinfection solution. - Those products support a contamination control strategy spanning sterilization, cleanroom disinfection and environmental monitoring. - PSC Biotech was founded in 1996. - The company says it serves more than 1,000 clients worldwide through consulting, equipment rentals and sales, cloud software and pharmaceutical contract manufacturing. - PSC Biotech operates three divisions: PSC Biotech, PSC Software and BioTechnique. - Clever Culture Systems is based in Adelaide, South Australia, and develops intelligent automation tools for microbiology laboratories. - Clever Culture Systems said APAS® Independence is already established with leading global pharmaceutical manufacturers.

Between the lines: - The partnership gives Clever Culture Systems a channel into mid-tier and regional U.S. manufacturers, a segment that can be harder to reach directly. - PSC Biotech is bundling the software-driven platform with its own compliance and validation services, which could lower adoption friction for regulated buyers. - The BioTechnique demo site is also a sales tool, not just a technical milestone.

What’s next: - PSC Biotech will begin promoting APAS® Independence through its pharmaceutical customer network. - Customers will be able to evaluate the system at BioTechnique in a live manufacturing environment. - The partnership is likely to focus first on manufacturers looking to improve microbiology testing efficiency while maintaining GMP readiness.

The bottom line: - PSC Biotech is adding an FDA-cleared AI microbiology platform to its contamination control portfolio and using its validation footprint to help push adoption in regulated pharma manufacturing.